Skip to content

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03832920
Acronym
ANIBPV
Enrollment
100
Registered
2019-02-06
Start date
2019-05-02
Completion date
2023-03-01
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

general anesthesia, paravertebral Block, analgesia nociception index

Brief summary

Paravertebral Block (PVB) combined with general anesthesia (GA) is a conventional pain treatment for breast surgery but sometimes failures can occurs. The efficacy of this block has to be evaluated. Also, for the intra-operative analgesic evaluation of this block, it is necessary to measure intra-operative analgesia index. A monitor of nociception for patients under GA, the PhysiodolorisTM device, offers an index for measuring nociceptive inputs during surgery in anesthetized patients : the ANI index (based on the single R-R interval analysis). The purpose of this observational and prospective study is to assess the variations of this ANI index during breast surgery with or without axillary node dissection with a PVB. This will allow us to quantify the analgesic effect of a PVB during GA for unilateral radical breast surgery with or without axillary node dissection.

Interventions

A monitor of nociception for patients under general anesthesia

Sponsors

Institut de Cancérologie de Lorraine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists score (ASA) I or II * Woman * Patients aged over 18 years * BMI between 17 and 30 kg/m2 * Radical mastectomy with or without axillary node dissection.

Exclusion criteria

* Preoperative consumption of opioid * Local Anesthesia allergy * Local skin inflammation at the puncture area * Inability to respond to pain assessment using a Numerical Rating Score (NRS) * Any contra-indication or patient's refusal for regional anesthesia B blocker medication * Pace maker * Inability to perform the PVB (at the appreciation of the anesthesiologist) * Change of surgical procedure other modified radical mastectomy with or without axillary node dissection. * Patient with a severe side effect or who cannot be controlled by additional therapy will be removed from the trial

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the ANI indexfirst minute of the surgical incisionAssessment of the area under the curve of the variation of the ANI index for the first minute of the surgical incision according to the PVB failure: incomplete or ineffective vs effective. The PVB failure will be evaluate with a cold test on the thoracic levels T2 and T6.

Secondary

MeasureTime frameDescription
Post Anesthesia Care Unit total dose of morphine will be compare according to the PVB failure or not groups.Just after surgery (day 0)Post Anesthesia Care Unit total dose of morphine will be compare according to the PVB failure or not groups.
Evaluation of painJust after surgery (day 0) and the day after surgery (day 1)Evaluation of the Numerical Rating Score (NRS) (no pain = 0, worst pain =10): NRS at arrival in the post anesthesia care unit , NRS at leaving of the post anesthesia care unit and at the postoperative day 1. NRS will be compare according to the PVB failure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026